CoChat

The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: An open label pilot study

Mezawa, Morito, Takemoto, Minoru, Onishi, Shunichiro, Ishibashi, Ryoichi, Ishikawa, Takahiro, Yamaga, Masaya, Fujimoto, Masaki, Okabe, Emiko, He, Peng, Kobayashi, Kazuki, Yokote, Koutaro · 2012 · BioFactors
Cited by 42

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Coenzyme Q10 (CoQ10) provides the energy for vital cellular functions and is known to act as an antioxidant. We conducted an open label study to examine the clinical effects of supplementation of the reduced form of CoQ10, ubiquinol, in addition to conventional glucose‐lowering agents in patients with type 2 diabetes. Nine subjects (3 males and 6 females) with type 2 diabetes and receiving conventional medication were recruited. The subjects were assigned to receive an oral dose of 200 mg ubiquinol daily for 12 weeks. The effect of ubiquinol on blood pressure, lipid profile, glycemic control, oxidative stress, and inflammation were examined before and after ubiquinol supplementation. In addition, five healthy volunteers were also assigned to receive an oral dose of 200 mg ubiquinol daily for 4 weeks to examine the effects of ubiquinol on insulin secretion. In patients with diabetes, there were no differences with respect to blood pressure, lipid profile, oxidative stress marker, and inflammatory markers. However, there were significant improvements in glycosylated hemoglobin (53.0 ± 4.3 to 50.5 ± 3.7 mmol/mol,P= 0.01) (7.1 ± 0.4 to 6.8 ± 0.4%,P= 0.03). In healthy volunteers, the insulinogenic index (0.65 ± 0.29 to 1.23 ± 0.56,P= 0.02) and the ratio of proinsulin to insulin were significantly improved (3.4 ± 1.8 to 2.1 ± 0.6,P= 0.03). The results of our study are consistent with the suggestion that the supplementation of ubiquinol in subjects with type 2 diabetes, in addition to conventional antihyperglycemic medications, improves glycemic control by improving insulin secretion without any adverse effects.© 2012 International Union of Biochemistry and Molecular Biology, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/biof.1038

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 42

Metadata

Authors
Mezawa, M., Takemoto, M., Onishi, S., Ishibashi, R., Ishikawa, T., Yamaga, M., Fujimoto, M., Okabe, E., He, P., Kobayashi, K., & Yokote, K.
Venue
BioFactors
Publisher
Wiley
Published
2012-08-08
Volume
38
Issue
6
Pages
416-421
ISSN
  • 0951-6433 (ISSN-L)
  • 1872-8081
OpenAlex
W2029962916
Cited by
42
References
7
FWCI
1.74
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: An open label pilot study. https://app.cochat.ai/papers/10.1002/biof.1038
The paper
Mezawa, M., Takemoto, M., Onishi, S., Ishibashi, R., Ishikawa, T., Yamaga, M., Fujimoto, M., Okabe, E., He, P., Kobayashi, K., & Yokote, K. (2012). The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: An open label pilot study. BioFactors. https://doi.org/10.1002/biof.1038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.